Do TPOAb, TgAb, CTLA4 rs231775 AG, and CD40 rs1883832 CC indicate autoimmune thyroid antibody formation?

Biomarkers of Thyroid Autoimmunity

• TPOAb and TgAb: Thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb) serve as primary, highly sensitive markers of thyroid-directed immune activity. Testing both antibodies concurrently achieves a diagnostic sensitivity of 95–97% for autoimmune thyroiditis, correlating strongly with active thyroid inflammation and histological lymphocytic infiltration.
• Pathological mechanisms: TPOAb directly promotes follicular cell injury by fixing complement and driving both complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC).

Immunogenetic Susceptibility

• CTLA4 rs231775 AG variant: The G allele (carried in the AG genotype) impairs the immune system's regulatory "brake" by reducing CTLA-4 glycosylation and cell-surface expression. This functional deficit leads to unchecked T-cell activation, robust B-cell help, and elevated levels of anti-TPO and anti-TG antibodies.
• CD40 rs1883832 CC variant: Located in the Kozak sequence of the CD40 gene, this genotype increases CD40 mRNA and protein expression. This overexpression enhances T-to-B cell interactions, directly driving higher titers of pathogenic TSH receptor autoantibodies (TRAb) in Graves' disease.

Bottom line

• TPOAb and TgAb are definitive indicators of active, destructive thyroid-directed immune processes. The CTLA4 rs231775 AG and CD40 rs1883832 CC genetic variants significantly increase susceptibility to autoimmune thyroiditis and Graves' disease, respectively, by disrupting T-cell regulation and amplifying antibody-producing pathways.